These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 15342309)
41. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Turley AJ; Raja SG; Salhiyyah K; Nagarajan K Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605 [TBL] [Abstract][Full Text] [Related]
42. Improved septal contraction and coronary flow velocity after cardiac resynchronization therapy elucidated by strain imaging and pulsed wave Doppler echocardiography. Kayano H; Ueda H; Kawamata T; Miyoshi F; Toshida T; Watanabe N; Hirano Y; Kawamura M; Asano T; Kou S; Tanno K; Ozawa M; Kobayashi Y; Katagiri T J Cardiol; 2006 Feb; 47(2):51-61. PubMed ID: 16515355 [TBL] [Abstract][Full Text] [Related]
43. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201 [TBL] [Abstract][Full Text] [Related]
44. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy. Glick A; Michowitz Y; Keren G; George J Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167 [TBL] [Abstract][Full Text] [Related]
45. Electrocardiographic remodeling during cardiac resynchronization therapy. Boriani G; Biffi M; Martignani C; Ziacchi M; Saporito D; Grigioni F; Domenichini G; Valzania C; Diemberger I; Bertini M; Specchia S; Branzi A Int J Cardiol; 2006 Apr; 108(2):165-70. PubMed ID: 15923048 [TBL] [Abstract][Full Text] [Related]
46. Cardiac resynchronisation therapy: evidence based benefits and patient selection. Albouaini K; Egred M; Rao A; Alahmar A; Wright DJ Eur J Intern Med; 2008 May; 19(3):165-72. PubMed ID: 18395159 [TBL] [Abstract][Full Text] [Related]
47. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function. Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936 [TBL] [Abstract][Full Text] [Related]
48. Cardiac resynchronization therapy for heart failure. Bax JJ; Van der Wall EE; Schalij MJ N Engl J Med; 2002 Nov; 347(22):1803-4; author reply 1803-4. PubMed ID: 12456861 [No Abstract] [Full Text] [Related]
51. Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier? Maass AH; van Veldhuisen DJ Eur J Heart Fail; 2010 Jun; 12(6):527-9. PubMed ID: 20498266 [No Abstract] [Full Text] [Related]
52. Resynchronization therapy is an important advance in the management of congestive heart failure: view of an antagonist. Jessup M J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S30-4. PubMed ID: 12950515 [TBL] [Abstract][Full Text] [Related]